Colgate-Palmolive Stock Price, News & Analysis (NYSE:CL)

$77.50 0.87 (1.14 %)
(As of 01/21/2018 05:53 AM ET)
Previous Close$77.50
Today's Range$76.80 - $77.91
52-Week Range$63.43 - $77.91
Volume4.48 million shs
Average Volume2.24 million shs
Market Capitalization$68.05 billion
P/E Ratio27.00
Dividend Yield2.06%
Beta0.8

About Colgate-Palmolive (NYSE:CL)

Colgate-Palmolive logoColgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia. The Company's oral care products include Colgate Total, Colgate Sensitive Pro-Relief, Colgate Max Fresh and Colgate Optic White. The Company is also engaged in various product categories of the personal care market with operations in liquid hand soap, which it sells under the Palmolive, Protex and Softsoap brands. The Company manufactures and markets a range of products for the home care market, including Palmolive and Ajax dishwashing liquids, Fabuloso and Ajax household cleaners and Murphy's Oil Soap. The Company, through its Hill's Pet Nutrition segment (Hill's), manufactures pet nutrition products for dogs and cats.

Receive CL News and Ratings via Email

Sign-up to receive the latest news and ratings for CL and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Personal Products
Sub-IndustryHousehold Products
SectorConsumer Staples
SymbolNYSE:CL
CUSIP19416210
Phone212-310-2000

Debt

Debt-to-Equity Ratio24.42%
Current Ratio1.23%
Quick Ratio0.92%

Price-To-Earnings

Trailing P/E Ratio27
Forward P/E Ratio27.00
P/E Growth3.24

Sales & Book Value

Annual Sales$15.20 billion
Price / Sales4.48
Cash Flow$3.34 per share
Price / Cash23.23
Book Value$0.02 per share
Price / Book3,875.00

Profitability

Trailing EPS$2.59
Net Income$2.44 billion
Net Margins15.10%
Return on Equity2,782.56%
Return on Assets20.45%

Miscellaneous

Employees36,700
Outstanding Shares878,100,000

Colgate-Palmolive (NYSE:CL) Frequently Asked Questions

What is Colgate-Palmolive's stock symbol?

Colgate-Palmolive trades on the New York Stock Exchange (NYSE) under the ticker symbol "CL."

How often does Colgate-Palmolive pay dividends? What is the dividend yield for Colgate-Palmolive?

Colgate-Palmolive announced a quarterly dividend on Thursday, January 11th. Investors of record on Tuesday, January 23rd will be paid a dividend of $0.40 per share on Thursday, February 15th. This represents a $1.60 annualized dividend and a dividend yield of 2.06%. The ex-dividend date of this dividend is Monday, January 22nd. View Colgate-Palmolive's Dividend History.

How were Colgate-Palmolive's earnings last quarter?

Colgate-Palmolive (NYSE:CL) issued its quarterly earnings data on Friday, October, 27th. The company reported $0.73 EPS for the quarter, meeting the consensus estimate of $0.73. The business had revenue of $3.97 billion for the quarter, compared to analyst estimates of $3.94 billion. Colgate-Palmolive had a net margin of 15.10% and a return on equity of 2,782.56%. The business's revenue for the quarter was up 2.8% on a year-over-year basis. During the same quarter last year, the business earned $0.73 EPS. View Colgate-Palmolive's Earnings History.

When will Colgate-Palmolive make its next earnings announcement?

Colgate-Palmolive is scheduled to release their next quarterly earnings announcement on Friday, January, 26th 2018. View Earnings Estimates for Colgate-Palmolive.

Where is Colgate-Palmolive's stock going? Where will Colgate-Palmolive's stock price be in 2018?

17 equities research analysts have issued twelve-month target prices for Colgate-Palmolive's stock. Their forecasts range from $66.00 to $85.00. On average, they anticipate Colgate-Palmolive's stock price to reach $75.86 in the next year. View Analyst Ratings for Colgate-Palmolive.

Who are some of Colgate-Palmolive's key competitors?

Who are Colgate-Palmolive's key executives?

Colgate-Palmolive's management team includes the folowing people:

  • Ian M. Cook, Chairman of the Board, President, Chief Executive Officer (Age 64)
  • Daniel B. Marsili, Chief Human Resource Officer (Age 56)
  • John J. Huston, Senior Vice President - Chief of Staff (Age 62)
  • Patricia Verduin Ph.D., Chief Technology Officer (Age 58)
  • Mukul V. Deoras, Chief Marketing Officer (Age 53)
  • Henning I. Jakobsen, Vice President, Corporate Controller (Age 57)
  • Victoria L. Dolan, Chief Transformation Officer (Age 57)
  • Delia H. Thompson, Chief Investor Relations Officer (Age 67)
  • Makarand Karnataki, Company Secretary and Compliance Officer
  • Jennifer M. Daniels, Chief Legal Officer and Secretary (Age 53)

Who owns Colgate-Palmolive stock?

Colgate-Palmolive's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Schwab Charles Investment Management Inc. (0.39%), Acadian Asset Management LLC (0.24%), Marathon Asset Management LLP (0.17%), Confluence Investment Management LLC (0.15%), National Pension Service (0.08%) and Gateway Investment Advisers LLC (0.08%). Company insiders that own Colgate-Palmolive stock include Daniel B Marsili, Delano E Lewis, Delia H Thompson, Dennis J Hickey, Ellen M Hancock, Fabian T Garcia, Franck J Moison, Ian M Cook, Jennifer Daniels, John J Huston, John T Cahill, Justin Skala, Mukul Deoras, Noel R Wallace, Patricia Verduin, Richard J Kogan, Stephen I Sadove and Victoria L Dolan. View Institutional Ownership Trends for Colgate-Palmolive.

Who sold Colgate-Palmolive stock? Who is selling Colgate-Palmolive stock?

Colgate-Palmolive's stock was sold by a variety of institutional investors in the last quarter, including Davis R M Inc., Exxonmobil Investment Management Inc. TX, Private Asset Management Inc., Wendell David Associates Inc., Oakbrook Investments LLC, Ingalls & Snyder LLC, Starfire Investment Advisers Inc. and Creative Planning. Company insiders that have sold Colgate-Palmolive company stock in the last year include Daniel B Marsili, Dennis J Hickey, Ellen M Hancock, Franck J Moison, Jennifer Daniels, John J Huston, John T Cahill, Justin Skala, Mukul Deoras, Patricia Verduin, Richard J Kogan, Stephen I Sadove and Victoria L Dolan. View Insider Buying and Selling for Colgate-Palmolive.

Who bought Colgate-Palmolive stock? Who is buying Colgate-Palmolive stock?

Colgate-Palmolive's stock was bought by a variety of institutional investors in the last quarter, including Acadian Asset Management LLC, State of Alaska Department of Revenue, LGT Capital Partners LTD., McCollum Christoferson Group LLC, Gateway Investment Advisers LLC, Marathon Asset Management LLP, Heritage Way Advisors LLC and National Pension Service. View Insider Buying and Selling for Colgate-Palmolive.

How do I buy Colgate-Palmolive stock?

Shares of Colgate-Palmolive can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Colgate-Palmolive's stock price today?

One share of Colgate-Palmolive stock can currently be purchased for approximately $77.50.

How big of a company is Colgate-Palmolive?

Colgate-Palmolive has a market capitalization of $68.05 billion and generates $15.20 billion in revenue each year. The company earns $2.44 billion in net income (profit) each year or $2.59 on an earnings per share basis. Colgate-Palmolive employs 36,700 workers across the globe.

How can I contact Colgate-Palmolive?

Colgate-Palmolive's mailing address is 300 PARK AVE, NEW YORK NY, 10022. The company can be reached via phone at 212-310-2000 or via email at [email protected]


MarketBeat Community Rating for Colgate-Palmolive (CL)

Community Ranking:  1.4 out of 5 (star)
Outperform Votes:  264 (Vote Outperform)
Underperform Votes:  658 (Vote Underperform)
Total Votes:  922
MarketBeat's community ratings are surveys of what our community members think about Colgate-Palmolive and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Colgate-Palmolive (NYSE:CL) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.242.242.252.15
Ratings Breakdown: 1 Sell Rating(s)
11 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
11 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
12 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
11 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $75.86$75.86$76.38$74.91
Price Target Upside: 2.52% upside2.52% upside0.84% upside2.24% upside

Colgate-Palmolive (NYSE:CL) Consensus Price Target History

Price Target History for Colgate-Palmolive (NYSE:CL)

Colgate-Palmolive (NYSE:CL) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
12/19/2017MacquarieUpgradeNeutral -> Outperform$81.00LowView Rating Details
12/13/2017Deutsche BankInitiated CoverageHold$75.00LowView Rating Details
11/29/2017Societe GeneraleDowngradeHold -> Sell$66.00MediumView Rating Details
11/25/2017KeyCorpReiterated RatingHoldLowView Rating Details
11/2/2017CitigroupLower Price TargetNeutral$76.00 -> $75.00N/AView Rating Details
10/31/2017Morgan StanleyLower Price TargetOverweight$84.00 -> $83.00N/AView Rating Details
10/30/2017Jefferies GroupLower Price TargetHold$79.00 -> $76.00N/AView Rating Details
10/29/2017Stifel NicolausSet Price TargetHold$73.00N/AView Rating Details
10/11/2017SunTrust BanksUpgradeHold -> Buy$65.00 -> $85.00N/AView Rating Details
10/8/2017Royal Bank of CanadaReiterated RatingHold$74.00N/AView Rating Details
7/24/2017Wells Fargo & CoReiterated RatingMarket PerformLowView Rating Details
5/31/2017Bank of AmericaBoost Price TargetBuy$78.00 -> $80.00LowView Rating Details
3/21/2017JPMorgan Chase & Co.Initiated CoverageNeutral -> Neutral$77.00LowView Rating Details
2/21/2017BNP ParibasUpgradeNeutral -> OutperformN/AView Rating Details
2/18/2017BarclaysSet Price TargetHold$75.00N/AView Rating Details
2/3/2017B. RileyReiterated RatingNeutral$74.00N/AView Rating Details
1/25/2017Berenberg BankInitiated CoverageHold$68.00N/AView Rating Details
7/29/2016Exane BNP ParibasDowngradeOutperform -> NeutralN/AView Rating Details
7/15/2016Goldman Sachs GroupReiterated RatingNeutral$74.00 -> $76.00N/AView Rating Details
6/1/2016Atlantic SecuritiesInitiated CoverageOverweightN/AView Rating Details
2/26/2016Sterne Agee CRTDowngradeBuy -> NeutralN/AView Rating Details
1/29/2016Canaccord GenuityReiterated RatingHold$66.50N/AView Rating Details
(Data available from 1/21/2016 forward)

Earnings

Colgate-Palmolive (NYSE:CL) Earnings History and Estimates Chart

Earnings by Quarter for Colgate-Palmolive (NYSE:CL)

Colgate-Palmolive (NYSE CL) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
1/26/2018$0.75N/AView Earnings Details
10/27/2017Q3 2017$0.73$0.73$3.94 billion$3.97 billionViewN/AView Earnings Details
7/21/2017Q2 2017$0.72$0.72$3.89 billion$3.83 billionViewN/AView Earnings Details
4/28/2017Q1 17$0.66$0.67$3.80 billion$3.76 billionViewN/AView Earnings Details
1/27/2017Q416$0.75$0.75$3.87 billion$3.72 billionViewN/AView Earnings Details
10/27/2016Q316$0.73$0.73$3.94 billion$3.87 billionViewListenView Earnings Details
7/28/2016Q216$0.69$0.70$3.86 billion$3.85 billionViewListenView Earnings Details
4/28/2016Q116$0.63$0.63$3.76 billion$3.76 billionViewListenView Earnings Details
1/29/2016Q415$0.72$0.73$3.94 billion$3.90 billionViewListenView Earnings Details
10/30/2015Q315$0.72$0.72$4.08 billion$4.00 billionViewListenView Earnings Details
7/30/2015Q215$0.70$0.70$4.07 billion$4.07 billionViewListenView Earnings Details
4/30/2015Q115$0.66$0.66$4.06 billion$4.07 billionViewN/AView Earnings Details
1/29/2015Q414$0.75$0.76$4.24 billion$4.22 billionViewN/AView Earnings Details
10/24/2014Q314$0.75$0.76$4.44 billion$4.38 billionViewListenView Earnings Details
7/31/2014Q214$0.73$0.73$4.41 billion$4.35 billionViewN/AView Earnings Details
4/25/2014Q114$0.68$0.68$4.32 billion$4.33 billionViewN/AView Earnings Details
1/31/2014Q413$0.74$0.75$4.40 billion$4.36 billionViewN/AView Earnings Details
10/24/2013Q313$0.73$0.73$4.46 billion$4.40 billionViewN/AView Earnings Details
7/25/2013Q2 2013$0.70$0.70$4.39 billion$4.35 billionViewN/AView Earnings Details
4/25/2013Q1 2013$1.32$1.32$4.30 billion$4.32 billionViewN/AView Earnings Details
1/31/2013Q4 2012$1.40$1.41$4.31 billion$4.29 billionViewN/AView Earnings Details
10/25/2012$1.39$1.38ViewN/AView Earnings Details
7/26/2012$1.33$1.33ViewN/AView Earnings Details
4/26/2012$1.24$1.24ViewN/AView Earnings Details
1/26/2012$1.30$1.30ViewN/AView Earnings Details
10/27/2011$1.30$1.31ViewN/AView Earnings Details
7/28/2011$1.25$1.26ViewN/AView Earnings Details
4/28/2011$1.16$1.16ViewN/AView Earnings Details
1/27/2011$1.23$1.24ViewN/AView Earnings Details
10/28/2010Q3 2010$0.60$0.61ViewN/AView Earnings Details
7/29/2010Q2 2010$0.58$0.59ViewN/AView Earnings Details
4/29/2010Q1 2010$0.58$0.61ViewN/AView Earnings Details
1/28/2010Q4 2009$0.59$0.60ViewN/AView Earnings Details
10/29/2009Q3 2009$0.56$0.56ViewN/AView Earnings Details
7/30/2009Q2 2009$0.52$0.54ViewN/AView Earnings Details
4/30/2009Q1 2009$0.49$0.48ViewN/AView Earnings Details
1/29/2009Q4 2008$0.49$0.50ViewN/AView Earnings Details
10/30/2008Q3 2008$0.49$0.50ViewN/AView Earnings Details
7/29/2008Q2 2008$0.47$0.49ViewN/AView Earnings Details
4/30/2008Q1 2008$0.44$0.45ViewN/AView Earnings Details
1/31/2008Q4 2007$0.45$0.45ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Colgate-Palmolive (NYSE:CL) Earnings Estimates

2018 EPS Consensus Estimate: $3.15
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181$0.77$0.77$0.77
Q2 20181$0.76$0.76$0.76
Q3 20182$0.76$0.81$0.79
Q4 20182$0.82$0.84$0.83
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Colgate-Palmolive (NYSE:CL) Dividend Information

Next Dividend:2/15/2018
Annual Dividend:$1.60
Dividend Yield:2.06%
Dividend Growth:3.80% (3 Year Average)
Payout Ratio:61.78% (Trailing 12 Months of Earnings)
55.75% (Based on This Year's Estimates)
50.63% (Based on Next Year's Estimates)
Track Record:54 Years of Consecutive Dividend Growth
Frequency:Quarterly Dividend
Dividend Payments by Quarter for Colgate-Palmolive (NYSE:CL)

Colgate-Palmolive (NYSE:CL) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
1/11/2018quarterly$0.402.12%1/22/20181/23/20182/15/2018
9/26/2017quarterly$0.402.19%10/20/201710/23/201711/15/2017
6/8/2017quarterly$0.402.11%7/14/20177/18/20178/15/2017
3/9/2017quarterly$0.402.15%4/19/20174/21/20175/15/2017
1/12/2017quarterly$0.392.37%1/19/20171/23/20172/15/2017
9/8/2016quarterly$0.392.2%10/20/201610/24/201611/15/2016
6/9/2016quarterly$0.392.16%7/20/20167/22/20168/15/2016
3/10/2016quarterly$0.392.28%4/20/20164/22/20165/16/2016
1/14/2016quarterly$0.382.4%1/21/20161/25/20162/16/2016
9/10/2015quarterly$0.382.45%10/21/201510/23/201511/16/2015
6/11/2015quarterly$0.382.29%7/21/20157/23/20158/14/2015
2/19/2015quarterly$0.382.16%4/21/20154/23/20155/15/2015
1/8/2015quarterly$0.362.1%1/21/20151/23/20152/16/2015
9/10/2014quarterly$0.362.24%10/15/201410/17/201411/14/2014
6/12/2014quarterly$0.362.12%7/16/20147/18/20148/15/2014
3/13/2014quarterly$0.362.26%4/17/20144/22/20145/15/2014
1/9/2014quarterly$0.342.09%1/22/20141/24/20142/14/2014
9/12/2013quarterly$0.342.29%10/18/201310/22/201311/15/2013
6/20/2013quarterly$0.342.39%7/19/20137/23/20138/15/2013
3/7/2013quarterly$0.682.35%4/19/20134/23/20135/15/2013
1/10/2013quarterly$0.622.32%1/22/20131/24/20132/15/2013
(Data available from 1/1/2013 forward)

Insider Trades

Colgate-Palmolive (NYSE CL) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 1.02%
Institutional Ownership Percentage: 72.86%
Insider Trades by Quarter for Colgate-Palmolive (NYSE:CL)
Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Colgate-Palmolive (NYSE CL) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/9/2018Jennifer DanielsInsiderSell902$75.82$68,389.6437,788View SEC Filing  
12/13/2017Jennifer DanielsInsiderSell7,375$73.18$539,702.5038,691View SEC Filing  
11/14/2017Victoria L DolanInsiderSell9,000$73.41$660,690.00View SEC Filing  
11/10/2017Mukul DeorasCMOSell7,500$73.28$549,600.0045,217View SEC Filing  
11/9/2017Justin SkalaCOOSell126,393$72.97$9,222,897.21262,361View SEC Filing  
11/9/2017Victoria L DolanInsiderSell10,000$73.07$730,700.0060,528View SEC Filing  
11/6/2017Stephen I SadoveDirectorSell20,780$70.52$1,465,405.6036,268View SEC Filing  
8/15/2017Patricia VerduinInsiderSell3,833$71.45$273,867.8553,173View SEC Filing  
8/10/2017John J HustonSVPSell14,000$71.36$999,040.0088,598View SEC Filing  
8/7/2017Franck J MoisonVice ChairmanSell35,000$71.52$2,503,200.00201,411View SEC Filing  
8/3/2017Dennis J HickeyCFOSell73,872$71.80$5,304,009.60484,985View SEC Filing  
8/1/2017Ellen M HancockDirectorSell5,057$71.91$363,648.87199,777View SEC Filing  
7/27/2017John T CahillDirectorSell8,000$72.47$579,760.0031,786View SEC Filing  
7/27/2017Justin SkalaCOOSell74,374$72.51$5,392,858.7497,177View SEC Filing  
7/17/2017Patricia VerduinInsiderSell3,833$72.41$277,547.5353,022View SEC Filing  
6/15/2017Patricia VerduinInsiderSell3,833$75.67$290,043.1153,022View SEC Filing  
5/10/2017John J HustonSVPSell14,000$71.53$1,001,420.00102,838View SEC Filing  
5/8/2017Richard J KoganDirectorSell8,000$71.92$575,360.0073,065View SEC Filing  
4/17/2017Daniel B MarsiliVPSell14,000$73.97$1,035,580.0073,904View SEC Filing  
4/17/2017Patricia VerduinInsiderSell3,833$73.72$282,568.7653,022View SEC Filing  
2/3/2017Stephen I SadoveDirectorSell8,000$66.00$528,000.0033,761View SEC Filing  
1/17/2017Patricia VerduinInsiderSell3,833$65.99$252,939.6754,924View SEC Filing  
1/9/2017Jennifer DanielsInsiderSell868$66.62$57,826.1636,813View SEC Filing  
12/15/2016Patricia VerduinInsiderSell3,834$65.66$251,740.4454,791View SEC Filing  
12/13/2016Jennifer DanielsInsiderSell7,072$66.78$472,268.1637,463View SEC Filing  
10/17/2016Patricia VerduinInsiderSell3,834$72.39$277,543.2655,013View SEC Filing  
9/15/2016Patricia VerduinInsiderSell3,834$71.85$275,472.9055,013View SEC Filing  
8/11/2016Franck J MoisonCOOSell15,000$75.16$1,127,400.00188,029View SEC Filing  
8/10/2016John J HustonSVPSell14,000$74.93$1,049,020.00102,761View SEC Filing  
8/10/2016Richard J KoganDirectorSell8,000$74.66$597,280.0076,065View SEC Filing  
8/8/2016Stephen I SadoveDirectorSell8,803$74.28$653,886.8426,474View SEC Filing  
8/2/2016Ellen M HancockDirectorSell4,584$74.82$342,974.88203,632View SEC Filing  
8/2/2016Noel R WallaceCOOSell78,849$74.69$5,889,231.81236,295View SEC Filing  
7/15/2016Patricia VerduinCTOSell3,666$74.98$274,876.6854,602View SEC Filing  
6/15/2016Patricia VerduinCTOSell3,666$72.19$264,648.5454,602View SEC Filing  
5/16/2016Patricia VerduinCTOSell3,666$71.59$262,448.9454,602View SEC Filing  
5/11/2016Ellen M HancockDirectorSell4,566$71.85$328,067.10199,742View SEC Filing  
5/11/2016John J HustonVPSell14,000$72.23$1,011,220.00101,843View SEC Filing  
5/11/2016Justin SkalaCOOSell89,200$72.17$6,437,564.0097,338View SEC Filing  
5/9/2016Noel R WallaceCOOSell8,931$72.06$643,567.86155,822View SEC Filing  
5/5/2016Delia H ThompsonVPSell40,000$72.08$2,883,200.00187,673View SEC Filing  
5/3/2016John T CahillDirectorSell16,000$72.30$1,156,800.0028,696View SEC Filing  
5/3/2016Noel R WallaceCOOSell60,000$72.16$4,329,600.00204,270View SEC Filing  
5/3/2016Victoria L DolanVPSell19,334$71.76$1,387,407.8455,526View SEC Filing  
4/15/2016Patricia VerduinCTOSell3,666$70.83$259,662.7854,602View SEC Filing  
3/8/2016Delia H ThompsonVPSell1,698$67.36$114,377.28147,673View SEC Filing  
3/8/2016Dennis J HickeyCFOSell5,420$67.36$365,091.20387,284View SEC Filing  
3/8/2016Franck J MoisonCOOSell6,661$67.36$448,684.96172,841View SEC Filing  
3/8/2016Ian M CookCEOSell25,238$67.36$1,700,031.681,281,800View SEC Filing  
3/8/2016Mukul DeorasCMOSell1,325$67.36$89,252.0046,866View SEC Filing  
3/8/2016Noel R WallaceInsiderSell5,238$67.36$352,831.68126,622View SEC Filing  
3/8/2016Patricia VerduinCTOSell1,953$67.36$131,554.0850,936View SEC Filing  
2/17/2016Dennis J. HickeyCFOSell50,697$67.05$3,399,233.85392,493View SEC Filing  
2/16/2016Fabian T. GarciaCOOSell145,000$65.72$9,529,400.00117,517View SEC Filing  
2/16/2016Patricia VerduinCTOSell3,666$66.58$244,082.2848,068View SEC Filing  
2/11/2016John J. HustonVPSell14,000$64.89$908,460.0086,438View SEC Filing  
2/10/2016Richard J. KoganDirectorSell8,000$66.27$530,160.0068,557View SEC Filing  
2/5/2016Delano E LewisDirectorSell200$65.92$13,184.0017,920View SEC Filing  
1/15/2016Patricia VerduinCTOSell3,666$62.37$228,648.4248,068View SEC Filing  
1/11/2016Jennifer DanielsInsiderSell837$62.85$52,605.4536,938View SEC Filing  
8/14/2015Ellen M HancockDirectorSell3,637$67.89$246,915.93View SEC Filing  
6/15/2015Daniel B MarsiliVPSell14,000$65.65$919,100.00View SEC Filing  
6/15/2015Patricia VerduinCTOSell3,333$65.64$218,778.12View SEC Filing  
5/15/2015Delano E LewisDirectorSell6,023$68.51$412,635.73View SEC Filing  
4/15/2015Daniel B MarsiliVPSell14,000$69.93$979,020.00View SEC Filing  
4/15/2015Patricia VerduinCTOSell3,333$69.89$232,943.37View SEC Filing  
3/9/2015Dennis J HickeyCFOSell18,224$69.49$1,266,385.76View SEC Filing  
3/9/2015Fabian T GarciaCOOSell10,137$69.49$704,420.13View SEC Filing  
3/9/2015Noel R WallaceInsiderSell6,638$69.49$461,274.62View SEC Filing  
3/9/2015Patricia VerduinCTOSell2,828$69.49$196,517.72View SEC Filing  
3/9/2015Victoria L DolanVPSell2,834$69.49$196,934.66View SEC Filing  
2/10/2015Ellen M HancockDirectorSell4,011$69.38$278,283.18View SEC Filing  
2/10/2015John J HustonVPSell14,000$69.19$968,660.00View SEC Filing  
2/5/2015Delano E LewisDirectorSell9,226$69.05$637,055.30View SEC Filing  
1/27/2015Andrew D HendryVice ChairmanSell10,000$65.29$652,900.00View SEC Filing  
1/15/2015Patricia VerduinCTOSell3,333$68.66$228,843.78View SEC Filing  
12/23/2014Andrew D HendryVice ChairmanSell10,000$70.39$703,900.00View SEC Filing  
12/15/2014Patricia VerduinCTOSell3,333$68.65$228,810.45View SEC Filing  
11/25/2014Andrew D HendryVice ChairmanSell10,000$67.94$679,400.00View SEC Filing  
11/25/2014Larisa HarrisonDirectorBuy2,000$0.29$570.00
11/17/2014Patricia VerduinCTOSell3,333$67.48$224,910.84View SEC Filing  
11/11/2014Andrew D HendryVice ChairmanSell10,000$68.46$684,600.00View SEC Filing  
10/29/2014Nigel BurtonCMOSell2,323$65.89$153,062.47View SEC Filing  
10/28/2014Andrew D HendryVice ChairmanSell10,000$66.32$663,200.00View SEC Filing  
9/23/2014Andrew D HendryVice ChairmanSell10,000$65.50$655,000.00View SEC Filing  
9/15/2014Patricia VerduinCTOSell3,337$64.27$214,468.99View SEC Filing  
9/9/2014Andrew D HendryVice ChairmanSell10,000$63.52$635,200.00View SEC Filing  
8/18/2014Delia H ThompsonVPSell40,000$64.75$2,590,000.00View SEC Filing  
8/18/2014Justin SkalaInsiderSell41,525$64.52$2,679,193.00View SEC Filing  
8/8/2014Franck J MoisonCOOSell24,888$64.73$1,611,000.24View SEC Filing  
8/5/2014Franck J MoisonCOOSell41,654$63.91$2,662,107.14View SEC Filing  
7/22/2014Andrew D HendryVice ChairmanSell10,000$68.73$687,300.00View SEC Filing  
7/15/2014Daniel B MarsiliVPSell15,500$69.71$1,080,505.00View SEC Filing  
7/10/2014Patricia VerduinCTOSell2,291$69.66$159,591.06View SEC Filing  
7/8/2014Andrew D HendryVice ChairmanSell10,000$68.64$686,400.00View SEC Filing  
6/24/2014Andrew D HendryVice ChairmanSell10,000$67.72$677,200.00View SEC Filing  
6/16/2014Daniel B MarsiliVPSell15,500$67.59$1,047,645.00View SEC Filing  
6/10/2014Andrew D HendryVice ChairmanSell6,000$68.57$411,420.00View SEC Filing  
5/27/2014Andrew D HendryVice ChairmanSell6,000$66.90$401,400.00View SEC Filing  
5/15/2014Patricia VerduinCTOSell2,000$66.86$133,720.0049,913View SEC Filing  
5/13/2014Andrew HendryVice ChairmanSell6,000$67.25$403,500.00185,726View SEC Filing  
5/13/2014Delano LewisDirectorSell2,100$67.19$141,099.0023,550View SEC Filing  
5/13/2014Dennis HickeyCFOSell51,352$67.18$3,449,827.36360,282View SEC Filing  
5/12/2014Daniel MarsiliVPSell15,500$67.37$1,044,235.0075,079View SEC Filing  
5/7/2014Stephen FogartyInsiderSell11,000$67.23$739,530.0023,809View SEC Filing  
5/2/2014Ronald MartinVPSell3,000$67.13$201,390.007,567View SEC Filing  
5/1/2014Delano LewisDirectorSell5,000$67.07$335,350.0023,642View SEC Filing  
5/1/2014Fabian GarciaCOOSell122,000$67.04$8,178,880.00193,936View SEC Filing  
4/22/2014Andrew HendryVice ChairmanSell6,000$66.89$401,340.00185,726View SEC Filing  
4/15/2014Patricia VerduinCTOSell2,000$66.09$132,180.0049,913View SEC Filing  
4/8/2014Andrew HendryVice ChairmanSell6,000$65.03$390,180.00185,726View SEC Filing  
3/17/2014Patricia VerduinCTOSell2,000$64.06$128,120.0049,913View SEC Filing  
2/28/2014Stephen FogartyInsiderSell12,000$63.10$757,200.0023,809View SEC Filing  
1/28/2014Andrew HendryVice ChairmanSell6,000$62.31$373,860.00192,093View SEC Filing  
12/24/2013Andrew HendryVice ChairmanSell6,000$64.80$388,800.00192,093View SEC Filing  
12/16/2013Patricia VerduinCTOSell2,000$64.14$128,280.0048,573View SEC Filing  
10/29/2013Michael CorboVPSell15,770$65.00$1,025,050.00View SEC Filing  
10/29/2013Nigel BurtonCMOSell19,862$65.51$1,301,159.62View SEC Filing  
10/29/2013Stephen J FogartyInsiderSell12,000$65.67$788,040.00View SEC Filing  
10/22/2013Andrew D HendryVice ChairmanSell6,000$62.40$374,400.00View SEC Filing  
10/15/2013Patricia VerduinCTOSell2,000$61.51$123,020.00View SEC Filing  
10/8/2013Andrew HendryVice ChairmanSell6,000$59.35$356,100.00192,547View SEC Filing  
9/24/2013Andrew HendryVice ChairmanSell6,000$60.00$360,000.00192,547View SEC Filing  
9/17/2013Michael CorboVPSell1,108$59.62$66,058.9625,177View SEC Filing  
9/17/2013Nigel BurtonCMOSell2,015$59.62$120,134.3045,139View SEC Filing  
9/17/2013Patricia VerduinCTOSell3,649$59.71$217,881.7948,414View SEC Filing  
9/17/2013Stephen FogartyInsiderSell1,035$59.62$61,706.7021,770View SEC Filing  
9/10/2013Andrew D HendryVice ChairmanSell6,000$58.79$352,740.00View SEC Filing  
8/15/2013Franck MoisonCOOSell12,400$60.28$747,472.00160,538View SEC Filing  
8/15/2013Guillenchmidt Alec DeInsiderSell3,888$60.28$234,368.6499,722View SEC Filing  
8/15/2013Patricia VerduinCTOSell2,000$60.28$120,560.0049,872View SEC Filing  
8/12/2013Delia ThompsonVPSell30,950$60.73$1,879,593.50146,551View SEC Filing  
8/12/2013Stephen FogartyInsiderSell12,000$60.64$727,680.0022,725View SEC Filing  
8/8/2013Nigel BurtonCMOSell18,667$61.06$1,139,807.0246,974View SEC Filing  
8/6/2013Elaine PaikVPSell7,141$60.94$435,172.5415,629View SEC Filing  
8/6/2013Mukul DeorasInsiderSell8,417$60.90$512,595.3030,058View SEC Filing  
7/31/2013Ronald T MartinVPSell1,800$60.27$108,486.00View SEC Filing  
7/30/2013Michael CorboVPSell10,000$60.21$602,100.00View SEC Filing  
7/15/2013Franck J MoisonCOOSell12,400$59.05$732,220.00View SEC Filing  
7/15/2013Justin SkalaInsiderSell4,822$59.03$284,642.66View SEC Filing  
7/15/2013Michael CorboVPSell2,000$59.13$118,260.00View SEC Filing  
6/17/2013Franck J MoisonCOOSell12,400$59.18$733,832.00View SEC Filing  
6/17/2013Guillenchmidt Alec DeInsiderSell3,888$59.09$229,741.92View SEC Filing  
6/17/2013Michael CorboVPSell2,000$59.09$118,180.00View SEC Filing  
6/4/2013Andrew D HendryVice ChairmanSell4,000$58.84$235,360.00View SEC Filing  
5/21/2013Andrew D HendryVice ChairmanSell6,000$61.63$369,780.00View SEC Filing  
5/15/2013Franck J MoisonCOOSell6,200$122.66$760,492.00View SEC Filing  
5/15/2013Guillenchmidt Alec DeInsiderSell1,944$122.66$238,451.04View SEC Filing  
5/15/2013Michael CorboVPSell1,000$122.66$122,660.00View SEC Filing  
5/13/2013Rosemary NelsonVPSell14,000$121.00$1,694,000.00View SEC Filing  
5/10/2013Dennis J HickeyCFOSell64,000$120.54$7,714,560.00View SEC Filing  
5/7/2013Andrew D HendryVice ChairmanSell6,000$120.37$722,220.00View SEC Filing  
4/30/2013Nigel BurtonCMOSell80,334$118.68$9,534,039.12View SEC Filing  
2/26/2013Daniel B MarsiliVPSell12,252$113.66$1,392,562.32View SEC Filing  
2/26/2013Justin SkalaInsiderSell5,894$113.64$669,794.16View SEC Filing  
12/4/2012Andrew D HendryVice ChairmanSell6,000$108.00$648,000.00View SEC Filing  
10/2/2012Andrew D HendryVice ChairmanSell6,000$108.27$649,620.00View SEC Filing  
9/4/2012Andrew D HendryVice ChairmanSell6,000$106.16$636,960.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Colgate-Palmolive (NYSE CL) News Headlines

Source:
DateHeadline
 Brokerages Expect Colgate-Palmolive (CL) Will Announce Earnings of $0.75 Per Share Brokerages Expect Colgate-Palmolive (CL) Will Announce Earnings of $0.75 Per Share
www.americanbankingnews.com - January 20 at 7:10 AM
Ex-Dividend Alert: Colgate-Palmolive Has Raised its Dividend Consecutively Since 1964; Will Trade Ex-Dividend on January 22, 2018Ex-Dividend Alert: Colgate-Palmolive Has Raised its Dividend Consecutively Since 1964; Will Trade Ex-Dividend on January 22, 2018
finance.yahoo.com - January 19 at 5:21 PM
Colgate-Palmolive (CL) to Release Quarterly Earnings on FridayColgate-Palmolive (CL) to Release Quarterly Earnings on Friday
www.americanbankingnews.com - January 19 at 1:10 AM
Ex-Dividend Reminder: Thyssen Krupp, Colgate-Palmolive and Cooper Companies - NasdaqEx-Dividend Reminder: Thyssen Krupp, Colgate-Palmolive and Cooper Companies - Nasdaq
www.nasdaq.com - January 18 at 10:57 AM
Will Higher Commodity Costs Hurt Kimberly-Clark’s Q4 Margins?Will Higher Commodity Costs Hurt Kimberly-Clark’s Q4 Margins?
finance.yahoo.com - January 18 at 10:57 AM
What Wall Street Analysts Recommend for KMB StockWhat Wall Street Analysts Recommend for KMB Stock
finance.yahoo.com - January 18 at 10:57 AM
Why Procter & Gamble’s Margins Could Disappoint in 2Q18Why Procter & Gamble’s Margins Could Disappoint in 2Q18
finance.yahoo.com - January 17 at 9:53 AM
Colgate-Palmolive Webcasts 2017 Fourth Quarter & Year-end Earnings Conference Call January 26, 2018 – 11:00 a.m. ETColgate-Palmolive Webcasts 2017 Fourth Quarter & Year-end Earnings Conference Call January 26, 2018 – 11:00 a.m. ET
finance.yahoo.com - January 16 at 10:01 AM
Colgate-Palmolive (CL) Lowered to Hold at Zacks Investment ResearchColgate-Palmolive (CL) Lowered to Hold at Zacks Investment Research
www.americanbankingnews.com - January 15 at 5:14 PM
Colgate-Palmolive (CL) Receives Consensus Recommendation of "Hold" from AnalystsColgate-Palmolive (CL) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - January 12 at 6:32 PM
Daily Dividend Report: BLK, CL, ALLY, EPD, LEN - Presented by: The Aol. On NetworkDaily Dividend Report: BLK, CL, ALLY, EPD, LEN - Presented by: The Aol. On Network
www.nasdaq.com - January 12 at 4:44 PM
Colgate-Palmolive (CL) Insider Jennifer Daniels Sells 902 SharesColgate-Palmolive (CL) Insider Jennifer Daniels Sells 902 Shares
www.americanbankingnews.com - January 12 at 12:36 AM
Colgate-Palmolive (CL) Announces $0.40 Quarterly DividendColgate-Palmolive (CL) Announces $0.40 Quarterly Dividend
www.americanbankingnews.com - January 11 at 5:08 PM
Colgate Declares Regular Quarterly DividendColgate Declares Regular Quarterly Dividend
finance.yahoo.com - January 11 at 5:01 PM
Colgate Palmolive: No Growth, High Price - Seeking AlphaColgate Palmolive: No Growth, High Price - Seeking Alpha
seekingalpha.com - January 10 at 10:05 AM
Colgate-Palmolive (CL) Expected to Post FY2018 Earnings of $3.32 Per ShareColgate-Palmolive (CL) Expected to Post FY2018 Earnings of $3.32 Per Share
www.americanbankingnews.com - January 9 at 4:02 PM
Morning Technical Insight on These Personal Products Stocks -- Procter & Gamble, Unilever, e.l.f. Beauty, and Colgate-PalmoliveMorning Technical Insight on These Personal Products Stocks -- Procter & Gamble, Unilever, e.l.f. Beauty, and Colgate-Palmolive
www.prnewswire.com - January 8 at 6:33 AM
[$$] Norwest Sells PCA Skin to Colgate-Palmolive[$$] Norwest Sells PCA Skin to Colgate-Palmolive
finance.yahoo.com - January 5 at 4:39 PM
Will Tough Operating Backdrop Continue to Hurt Campbell?Will Tough Operating Backdrop Continue to Hurt Campbell?
finance.yahoo.com - January 5 at 4:39 PM
Colgate-Palmolive (CL) Expected to Announce Quarterly Sales of $3.92 BillionColgate-Palmolive (CL) Expected to Announce Quarterly Sales of $3.92 Billion
www.americanbankingnews.com - January 5 at 11:06 AM
Colgate-Palmolive (CL) Announces Acquisition of PCA SKIN from Norwest Venture PartnersColgate-Palmolive (CL) Announces Acquisition of PCA SKIN from Norwest Venture Partners
www.streetinsider.com - January 5 at 10:07 AM
Colgate-Palmolive (CL) Announces Acquisition of PCA SKIN from Norwest Venture Partners - StreetInsider.comColgate-Palmolive (CL) Announces Acquisition of PCA SKIN from Norwest Venture Partners - StreetInsider.com
www.streetinsider.com - January 4 at 4:53 PM
Colgate-Palmolive a Slow But Steady ‘Dividend Aristocrat’Colgate-Palmolive a Slow But Steady ‘Dividend Aristocrat’
investorplace.com - December 30 at 12:24 PM
Colgate-Palmolive a Slow But Steady ‘Dividend Aristocrat’Colgate-Palmolive a Slow But Steady ‘Dividend Aristocrat’
investorplace.com - December 30 at 11:48 AM
Why Colgate-Palmolive’s Sales Are Expected to Rise in 2018Why Colgate-Palmolive’s Sales Are Expected to Rise in 2018
finance.yahoo.com - December 29 at 10:26 AM
Is Colgate-Palmolive Company’s (NYSE:CL) Balance Sheet Strong Enough To Weather A Storm?Is Colgate-Palmolive Company’s (NYSE:CL) Balance Sheet Strong Enough To Weather A Storm?
finance.yahoo.com - December 27 at 5:25 PM
Colgate (CL) Loses 13.9% YTD: Whats Hurting the Stock? - NasdaqColgate (CL) Loses 13.9% YTD: What's Hurting the Stock? - Nasdaq
www.nasdaq.com - December 22 at 10:07 AM
New Brands to Boost Colgates Personal Care Range in 2018New Brands to Boost Colgate's Personal Care Range in 2018
finance.yahoo.com - December 21 at 4:55 PM
Colgate (CL) Loses 13.9% YTD: Whats Hurting the Stock?Colgate (CL) Loses 13.9% YTD: What's Hurting the Stock?
www.zacks.com - December 21 at 4:55 PM
Morgan Stanleys top beverage and household products picks - Seeking AlphaMorgan Stanley's top beverage and household products picks - Seeking Alpha
seekingalpha.com - December 21 at 10:00 AM
Colgate (CL) Loses 13.9% YTD: What's Hurting the Stock?Colgate (CL) Loses 13.9% YTD: What's Hurting the Stock?
finance.yahoo.com - December 21 at 10:00 AM
ETFs with exposure to Colgate-Palmolive Co. : December 20, 2017ETFs with exposure to Colgate-Palmolive Co. : December 20, 2017
finance.yahoo.com - December 20 at 4:52 PM
UPDATE: Macquarie Upgrades Colgate-Palmolive Company (CL) to Outperform - StreetInsider.comUPDATE: Macquarie Upgrades Colgate-Palmolive Company (CL) to Outperform - StreetInsider.com
www.streetinsider.com - December 20 at 10:03 AM
New Brands to Boost Colgate's Personal Care Range in 2018New Brands to Boost Colgate's Personal Care Range in 2018
finance.yahoo.com - December 20 at 10:03 AM
Wired News – Colgate Palmolive Announces Acquisition of PCA Skin and EltaMD Skin Care BrandsWired News – Colgate Palmolive Announces Acquisition of PCA Skin and EltaMD Skin Care Brands
finance.yahoo.com - December 20 at 10:03 AM
Colgate-Palmolive (CL) Raised to Outperform at MacquarieColgate-Palmolive (CL) Raised to Outperform at Macquarie
www.americanbankingnews.com - December 19 at 9:44 PM
Colgate-Palmolive Set To Outperform In 2018, According To MacquarieColgate-Palmolive Set To Outperform In 2018, According To Macquarie
www.benzinga.com - December 19 at 4:52 PM
Colgate-Palmolive (CL) Rating Lowered to Sell at Zacks Investment ResearchColgate-Palmolive (CL) Rating Lowered to Sell at Zacks Investment Research
www.americanbankingnews.com - December 19 at 4:04 PM
UPDATE: Macquarie Upgrades Colgate-Palmolive Company (CL) to OutperformUPDATE: Macquarie Upgrades Colgate-Palmolive Company (CL) to Outperform
www.streetinsider.com - December 19 at 10:02 AM
Colgate acquires PCA Skin, EltaMDColgate acquires PCA Skin, EltaMD
www.bizjournals.com - December 19 at 10:02 AM
Colgate-Palmolive (CL) Expected to Announce Quarterly Sales of $3.91 BillionColgate-Palmolive (CL) Expected to Announce Quarterly Sales of $3.91 Billion
www.americanbankingnews.com - December 19 at 4:00 AM
Colgate-Palmolive (CL) Receives Average Recommendation of "Hold" from AnalystsColgate-Palmolive (CL) Receives Average Recommendation of "Hold" from Analysts
www.americanbankingnews.com - December 18 at 7:58 PM
Colgate-Palmolive (CL) to Purchase PCA Skin and EltaMDColgate-Palmolive (CL) to Purchase PCA Skin and EltaMD
www.streetinsider.com - December 18 at 4:51 PM
Colgate-Palmolive To Buy PCA Skin, EltaMD Skin Care Brands; Terms UndisclosedColgate-Palmolive To Buy PCA Skin, EltaMD Skin Care Brands; Terms Undisclosed
www.nasdaq.com - December 18 at 4:51 PM
Colgate-Palmolive Enters Professional Skincare Market With Key Acquisitions PCA Skin And EltaMDColgate-Palmolive Enters Professional Skincare Market With Key Acquisitions PCA Skin And EltaMD
finance.yahoo.com - December 18 at 4:51 PM
Colgate-Palmolive (CL) to Purchase PCA Skin and EltaMD - StreetInsider.comColgate-Palmolive (CL) to Purchase PCA Skin and EltaMD - StreetInsider.com
www.streetinsider.com - December 18 at 10:19 AM
Colgate Announces Acquisition of PCA Skin and EltaMD Skin Care BrandsColgate Announces Acquisition of PCA Skin and EltaMD Skin Care Brands
finance.yahoo.com - December 18 at 10:19 AM
Colgate-Palmolive fires off skin care dealsColgate-Palmolive fires off skin care deals
seekingalpha.com - December 18 at 9:46 AM
Colgate-Palmolive (CL) Expected to Announce Earnings of $0.75 Per ShareColgate-Palmolive (CL) Expected to Announce Earnings of $0.75 Per Share
www.americanbankingnews.com - December 17 at 7:26 PM
Colgate-Palmolive (CL) Insider Sells $539,702.50 in StockColgate-Palmolive (CL) Insider Sells $539,702.50 in Stock
www.americanbankingnews.com - December 15 at 6:04 PM

SEC Filings

Colgate-Palmolive (NYSE:CL) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Colgate-Palmolive (NYSE:CL) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Colgate-Palmolive (NYSE CL) Stock Chart for Sunday, January, 21, 2018

Loading chart…

This page was last updated on 1/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.